[Sclerodermal microangiopathy: a cause or a consequence?].
作者信息
Fiessinger J N, Kazandjian S, Camilleri J P, Debure C, Housset E
出版信息
Ann Med Interne (Paris). 1984;135(8):591-3.
PMID:6529053
Abstract
Microangiopathy is an essential clinicopathological feature of systemic scleroderma, comprising capillary thinning, thickening of the basement membrane and abnormalities of the endothelium which has an abnormally high uptake of radioactive thymidine. The identification of a circulating cytotoxic factor for endothelial cells suggests that the microangiopathy may play a role in the physiopathogenesis of the disease. In practice, microangiopathy can be fully assessed by capillaroscopy in patients with systemic scleroderma.
摘要
相似文献
1
[Sclerodermal microangiopathy: a cause or a consequence?].
Ann Med Interne (Paris). 1984;135(8):591-3.
2
[How to explore the microangiopathy of collagen diseases].[如何探索胶原病的微血管病变]
J Mal Vasc. 1985;10(4):281-5.
3
4
The pathology of scleroderma vascular disease.硬皮病血管疾病的病理学
Rheum Dis Clin North Am. 2008 Feb;34(1):41-55; vi. doi: 10.1016/j.rdc.2008.01.001.
5
6
Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis.甲襞毛细血管中红细胞流速降低作为系统性硬化症微循环损伤的敏感且特异指标。
Rheumatology (Oxford). 2009 Jun;48(6):696-703. doi: 10.1093/rheumatology/kep066.
7
Microvascular involvement in systemic sclerosis: capillaroscopic findings.系统性硬化症中的微血管受累：毛细血管镜检查结果
Semin Arthritis Rheum. 2001 Jun;30(6):397-402. doi: 10.1053/sarh.2001.20269.
8
Vascular abnormalities in scleroderma.硬皮病中的血管异常。
Semin Cutan Med Surg. 1998 Mar;17(1):12-7. doi: 10.1016/s1085-5629(98)80056-4.
9
Pathogenesis and staging of scleroderma.
Acta Derm Venereol. 1976;56(2):83-92.
10
Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.系统性硬化症中血管损伤的机制——对血管治疗策略的启示
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v18-20. doi: 10.1093/rheumatology/ken267.
Zotero 插件